{"nct_id":"NCT06491914","title":"A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2024-07-24","start_date_type":"ACTUAL","primary_completion_date":"2025-08-21","primary_completion_date_type":"ESTIMATED","completion_date":"2027-01-07","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["REGN"]}